Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
TB-500 is a synthetic peptide modeled after thymosin beta-4 and is commonly examined in animal models for its influence on cell migration, actin regulation, and muscle repair
Key Research Points at a Glance A 15-amino-acid fragment of a gastric-juice-derived protective protein, first characterised in the early 1990s Primary research mechanisms: angiogenesis (VEGF pathway) and gastric/gut-lining signalling Secondary mechanisms under study: growth factor modulation (EGF, FGF) and nitric oxide system interaction Frequently co-researched with TB-500 despite acting through an unrelated mechanism The large majority of published research is pre-clinical (in-vitro and animal-model), not human clinical data Notably stable across a wider pH/temperature range than many comparable research peptides What Is BPC-157
The peptides' ability to stimulate angiogenesis makes them an interesting focus in research aimed at optimizing physical performance and recovery
Food and Drug Administration warned consumers to immediately stop using Hydroxycut products by Iovate Health Sciences Inc., of Oakville, Ontario and distributed by Iovate Health Sciences USA Inc
